WELL LEAD MEDICAL CO., LTD. Well Lead Medical Co., Ltd. Stock
Equities
603309
CNE1000021C2
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.27 CNY | +3.51% |
|
+7.89% | -6.75% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 1.74B 240M | Sales 2025 * | 2.08B 288M | Capitalization | 3.89B 538M |
|---|---|---|---|---|---|
| Net income 2024 * | 243M 33.64M | Net income 2025 * | 297M 41.11M | EV / Sales 2024 * | 2.24 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.87 x |
| P/E ratio 2024 * |
16
x | P/E ratio 2025 * |
13.1
x | Employees | 2,622 |
| Yield 2024 * |
2.03% | Yield 2025 * |
2.49% | Free-Float | 42.15% |
More Fundamentals
* Assessed data
More news
| 1 day | +3.51% | ||
| 1 week | +7.89% | ||
| Current month | +7.89% | ||
| 1 month | +19.01% | ||
| 3 months | +23.21% | ||
| 6 months | -8.80% | ||
| Current year | -6.75% |
1 week
12.39
13.39
1 month
9.5613.39
Current year
8.5214.56
1 year
8.5219.78
3 years
8.5224.09
5 years
8.5224.09
10 years
6.4239.42
| Managers | Title | Age | Since |
|---|---|---|---|
Guang Yuan Han
CEO | Chief Executive Officer | 60 | 03-12-31 |
Guo Zhu Cai
BRD | Director/Board Member | 48 | 10-12-31 |
Yun Gui Chen
BRD | Director/Board Member | 49 | 03-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Bin Xiang
CHM | Chairman | 55 | 03-12-31 |
Guang Yuan Han
CEO | Chief Executive Officer | 60 | 03-12-31 |
Song Feng Duan
BRD | Director/Board Member | 55 | 11-06-08 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-09 | 13.27 | +3.51% | 7,328,783 |
| 24-05-08 | 12.82 | +0.79% | 6,770,797 |
| 24-05-07 | 12.72 | +1.35% | 5,585,700 |
| 24-05-06 | 12.55 | +2.03% | 5,923,703 |
End-of-day quote Shanghai S.E., May 08, 2024
More quotes
WELL LEAD MEDICAL CO., LTD. is a China-based company principally engaged in the research, development, manufacture and sales of catheters used for anesthesia, urinary, breathing, blood dialysis and other fields. The Company's major products include endotracheal intubations, urethral catheters, laryngeal masks, hemodialysis catheters and others. The Company's products are mainly applied in medical fields such as surgery, treatment, emergency treatment and nursing. The Company distributes its products in domestic market and overseas markets.
Calendar
2024-07-31
- Q2 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
13.27
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -6.75% | 539M | |
| -4.91% | 182B | |
| +0.46% | 110B | |
| -3.62% | 67.92B | |
| +3.26% | 50.96B | |
| +9.11% | 44.7B | |
| +2.44% | 40.66B | |
| +6.39% | 27.6B | |
| +3.83% | 26.63B | |
| +14.02% | 24.84B |
- Stock Market
- Equities
- 603309 Stock